The association between erectile dysfunction and peripheral arterial disease as determined by screening ankle-brachial index testing

Atherosclerosis

Volumn 207, Issue 2, 2009, Pages 440-444

  Polonsky, Tamar S ^a   Taillon, Linda A ^a   Sheth, Harshal ^a   Min, James K ^a   Archer, Stephen L ^a   Ward, R Parker ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Erectile dysfunction; Nitric oxide; Peripheral vascular disease

Indexed keywords

ADULT; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; EXERCISE TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SCREENING; SYMPTOM;

ADULT; AGED; ANKLE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BRACHIAL ARTERY; ERECTILE DYSFUNCTION; EXERCISE TEST; HUMANS; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 70450255311     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.05.005     Document Type: Article

References (33)

1. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
2. Newman A.B., Sutton-Tyrrell K., Vogt M.T., and Kuller L.H. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 270 (1993) 487-489
3. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 113 (2006) e463-e654
4. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
5. McDermott M.M., Hahn E.A., Greenland P., et al. Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. J Gen Intern Med 17 (2002) 895-904
6. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 270 (1993) 83-90
7. Jackson G., Rosen R.C., Kloner R.A., and Kostis J.B. The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. J Sex Med 3 (2006) 28-36
8. Grover S.A., Lowensteyn I., Kaouache M., et al. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease. Arch Intern Med 166 (2006) 213-219
9. Maas R., Schwedhelm E., Albsmeier J., and Boger R.H. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 7 (2002) 213-225
10. Montorsi F., Briganti A., Salonia A., et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 44 (2003) 360-364
11. Gazzaruso C., Solerte S.B., Pujia A., et al. Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. J Am Coll Cardiol 51 (2008) 2040-2044
12. Ma R.C., So W.Y., Yang X., et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 51 (2008) 2045-2050
13. Rosen R.C., Cappelleri J.C., and Gendrano III N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 14 (2002) 226-244
14. Leng G.C., and Fowkes F.G. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 45 (1992) 1101-1109
15. Skoumal R., Chen J., Kula K., et al. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction. Eur Urol 46 (2004) 362-369
16. Ward R.P., Weiner J., Taillon L.A., Ghani S.N., Min J.K., and Williams K.A. Comparison of findings on stress myocardial perfusion imaging in men with versus without erectile dysfunction and without prior heart disease. Am J Cardiol 101 (2008) 502-505
17. Hachamovitch R., Berman D.S., Kiat H., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93 (1996) 905-914
18. Saigal C.S., Wessells H., Pace J., Schonlau M., and Wilt T.J. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 166 (2006) 207-212
19. Gazzaruso C., Giordanetti S., De A.E., et al. Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients. Circulation 110 (2004) 22-26
20. Min J.K., Williams K.A., Okwuosa T.M., Bell G.W., Panutich M.S., and Ward R.P. Prediction of coronary heart disease by erectile dysfunction in men referred for nuclear stress testing. Arch Intern Med 166 (2006) 201-206
21. Thompson I.M., Tangen C.M., Goodman P.J., Probstfield J.L., Moinpour C.M., and Coltman C.A. Erectile dysfunction and subsequent cardiovascular disease. JAMA 294 (2005) 2996-3002
22. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
23. Grundy S.M., Cleeman J.I., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
24. Mehler P.S., Coll J.R., Estacio R., Esler A., Schrier R.W., and Hiatt W.R. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 107 (2003) 753-756
25. Mohler III E.R., Hiatt W.R., and Creager M.A. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation 108 (2003) 1481-1486
26. Hirsch A.T., Murphy T.P., Lovell M.B., et al. Gaps in public knowledge of peripheral arterial disease: the first national PAD public awareness survey. Circulation 116 (2007) 2086-2094
27. McDermott M.M., Liu K., Greenland P., et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA 292 (2004) 453-461
28. McDermott M.M., Guralnik J.M., Tian L., et al. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol 53 (2009) 1056-1062
29. Blumentals W.A., Gomez-Caminero A., Joo S., and Vannappagari V. Is erectile dysfunction predictive of peripheral vascular disease?. Aging Male 6 (2003) 217-221
30. Kaiser D.R., Billups K., Mason C., Wetterling R., Lundberg J.L., and Bank A.J. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 43 (2004) 179-184
31. Giuliano F. New horizons in erectile and endothelial dysfunction research and therapies. Int J Impot Res 20 Suppl 2 (2008) S2-S8
32. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 23 Suppl 1 (2004) III27-III32
33. Bush P.A., Aronson W.J., Buga G.M., Rajfer J., and Ignarro L.J. Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J Urol 147 (1992) 1650-1655